Jiebin Fang

ORCID

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Venues

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Zhen Tang, Ningjing Zhang, Shuang Chen, Jiebin Fang, Xinyi Tang, Yijie Lou, Yongjun Jiang, Yijun Ma, Xiaoming Chen, Zhe Chen, Shuai Zhan, Xia Ding, Wanjing Ding, Zhong-Jun Ma
Bipyridine Derivatives as NOP2/Sun RNA Methyltransferase 3 Inhibitors for the Treatment of Colorectal Cancer. Journal of medicinal chemistry (2024)
Xiaoming Chen, Xia Ding, Jiebin Fang, Churu Mao, Xingzhi Gong, Yuxiao Zhang, Ningjing Zhang, Feihang Yan, Yijie Lou, Zhe Chen, Wanjing Ding, Zhong-Jun Ma
Natural Derivatives of Selective HDAC8 Inhibitors with Potent in Vivo Antitumor Efficacy against Breast Cancer. Journal of medicinal chemistry (2024)
Xiaoming Chen, Xia Ding, Jiebin Fang, Churu Mao, Xingzhi Gong, Yuxiao Zhang, Ningjing Zhang, Feihang Yan, Yijie Lou, Zhe Chen, Wanjing Ding, Zhong-Jun Ma
Natural Derivatives of Selective HDAC8 Inhibitors with Potent in Vivo Antitumor Efficacy against Breast Cancer. Journal of medicinal chemistry 67 (16) (2024)
Zhen Tang, Ningjing Zhang, Shuang Chen, Jiebin Fang, Xinyi Tang, Yijie Lou, Yongjun Jiang, Yijun Ma, Xiaoming Chen, Zhe Chen, Shuai Zhan, Xia Ding, Wanjing Ding, Zhong-Jun Ma
Bipyridine Derivatives as NOP2/Sun RNA Methyltransferase 3 Inhibitors for the Treatment of Colorectal Cancer. Journal of medicinal chemistry 67 (15) (2024)
Zhen Tang, Ningjing Zhang, Shuang Chen, Jiebin Fang, Xinyi Tang, Yijie Lou, Yongjun Jiang, Yijun Ma, Xiaoming Chen, Zhe Chen, Shuai Zhan, Xia Ding, Wanjing Ding, Zhong-Jun Ma
Bipyridine Derivatives as NOP2/Sun RNA Methyltransferase 3 Inhibitors for the Treatment of Colorectal Cancer. Journal of medicinal chemistry 67 (15) (2024)
Xiaoming Chen, Xia Ding, Jiebin Fang, Churu Mao, Xingzhi Gong, Yuxiao Zhang, Ningjing Zhang, Feihang Yan, Yijie Lou, Zhe Chen, Wanjing Ding, Zhong-Jun Ma
Natural Derivatives of Selective HDAC8 Inhibitors with Potent in Vivo Antitumor Efficacy against Breast Cancer. Journal of medicinal chemistry 67 (16) (2024)

Jiebin Fang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jiebin Fang